A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice. (Q50478862)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 February 2014

Language	Label	Description	Also known as
English	A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice.	scientific article published on 18 February 2014

Statements

scholarly article

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

A large-scale, prospective, observational study of leukocytapheresis for ulcerative colitis: treatment outcomes of 847 patients in clinical practice. (English)

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

18

object named as

Toshifumi Hibi

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

author name string

Yoko Yokoyama

1

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Katsuyoshi Matsuoka

2

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Taku Kobayashi

3

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Koji Sawada

4

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tateshi Fujiyoshi

5

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Takafumi Ando

6

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Yoshifumi Ohnishi

7

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tetsuya Ishida

8

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Masashi Oka

9

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Masahiro Yamada

10

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Takashi Nakamura

11

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tomoko Ino

12

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Toyoko Numata

13

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Hirofumi Aoki

14

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Jun-Ichi Sakou

15

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Masahiro Kusada

16

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Tomoki Maekawa

17

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

publication date

18 February 2014

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Journal of Crohn's and Colitis

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

8

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

9

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

981-991

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

Clinical aspects and pathophysiology of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Defects in mucosal immunity leading to ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Cortisone and corticotrophin in ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Side effects of corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Preliminary data on the use of apheresis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Leukocytapheresis (LCAP) in the management of chronic active ulcerative colitis--results of a randomized pilot trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Infliximab for induction and maintenance therapy for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Granulocytapheresis in steroid-dependent and steroid-resistant patients with inflammatory bowel disease: a prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Fluctuations in peripheral blood leukocyte and platelet counts and leukocyte recruitment with large volume leukocytapheresis in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

A prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Clinical implications of mucosal healing for the management of IBD.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

From randomized controlled trials to observational studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2014.01.027

21 January 2018

Identifiers

10.1016/J.CROHNS.2014.01.027

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

1 reference

Europe PubMed Central

14 March 2018

http://europepmc.org/abstract/MED/24556083

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50478862&oldid=1569245326"